NeoStem Inc

(AMEX: NBS)

Industry: Biotechnology
On the web: http://www.neostem.com
Employees: 11

NeoStem, Inc. was incorporated under the laws of the State of Delaware in September 1980 under the name Fidelity Medical Services, Inc. On August 29, 2006, the Company's stockholders approved an amendment to its Certificate of Incorporation to change its name from Phase III Medical, Inc. to NeoStem, Inc. The Company provides adult stem cell processing, collection and banking services with the goal of making stem cell collection and storage widely available, so that the general population would have the opportunity to store their own stem cells for future healthcare needs. It is managing a network of adult stem cell collection centers in major metropolitan areas of the United States. The Company has also entered the research and development arenas, through the acquisition of a worldwide exclusive license to an early-stage technology to identify and isolate rare stem cells from adult human bone marrow, called VSEL (very small embryonic-like) stem cells. VSELs have many physical characteristics typically found in embryonic stem cells, including the ability to differentiate into specialized cells found in substantially all the different types of cells and tissue that make up the body. The Company might face competition from companies with far greater financial, marketing, technical and research resources, name recognition, distribution channels and market presence than it, who are marketing or developing new services that are similar to the services that are now being or might in the future be developed by it. The Company operates in a highly regulated environment, and the failure to comply with applicable regulations, registrations and approvals would materially and adversely affect its business.